Literature DB >> 1909938

Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas.

R A Koza1, L C Megosh, M Palmieri, T G O'Brien.   

Abstract

Epidermal papillomas were induced in CD-1 mice by a single topical application of 7,12-dimethylbenzanthracene (DMBA) followed by twice weekly applications of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in acetone. Control groups consisted of mice treated singly or chronically with acetone or TPA. TPA induced a rapid, yet transient 500- to 1000-fold increase in ornithine decarboxylase (ODC) activity which resulted in a 2- to 8.4-fold elevation of putrescine in both singly or chronically TPA-treated mouse epidermis 4-6 h after its application. After 24 h, levels of spermidine, but not spermine, were also elevated. The ODC and arginase activities in the 11 individual papillomas studied averaged 400- and 26-fold higher respectively than basal levels in epidermis. The activity of ODC in most papillomas, unlike ODC in epidermis, could be stimulated by guanosine 5'-triphosphate (GTP). Putrescine and spermidine levels in papillomas, especially those exhibiting highly GTP-stimulated ODC, were substantially higher compared to either normal or TPA-treated epidermis. Although epidermis contains a relatively high ornithine content, its level is even further elevated in papillomas, in some cases as much as 70-fold. The consequences of the constitutively elevated polyamine levels in papillomas caused by the loss of control over the normally tightly regulated polyamine biosynthetic pathway are not known, but could be important in regulating the balance between proliferation and differentiation in this self-renewing epithelial tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909938     DOI: 10.1093/carcin/12.9.1619

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.

Authors:  K A Skorupski; T G O'Brien; T Guerrero; C O Rodriguez; M R Burns
Journal:  Vet Comp Oncol       Date:  2011-03-08       Impact factor: 2.613

2.  Polyamines regulate gap junction communication in connexin 43-expressing cells.

Authors:  L Shore; P McLean; S K Gilmour; M B Hodgins; M E Finbow
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.

Authors:  Candace S Hayes; Karen DeFeo-Mattox; Patrick M Woster; Susan K Gilmour
Journal:  Amino Acids       Date:  2013-07-25       Impact factor: 3.520

4.  S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Authors:  Chenxu Shi; Timothy K Cooper; Diane E McCloskey; Adam B Glick; Lisa M Shantz; David J Feith
Journal:  Carcinogenesis       Date:  2012-05-19       Impact factor: 4.944

5.  Superinduction of mouse epidermal ornithine decarboxylase activity by repeated 12-o-tetradecanoylphorbol-13-acetate treatments.

Authors:  A K Verma; K M Hsiao; H Ahrens; M Suganuma; H Fujiki; S Matsufuji; H Hayashi
Journal:  Mol Cell Biochem       Date:  1996-02-23       Impact factor: 3.396

6.  Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis.

Authors:  Patricia A Welsh; Suzanne Sass-Kuhn; Chethana Prakashagowda; Diane McCloskey; David Feith
Journal:  Cancer Biol Ther       Date:  2012-04-01       Impact factor: 4.742

Review 7.  Polyamines and nonmelanoma skin cancer.

Authors:  Susan K Gilmour
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-29       Impact factor: 4.219

8.  Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.

Authors:  Candace S Hayes; Allyson C Shicora; Martin P Keough; Adam E Snook; Mark R Burns; Susan K Gilmour
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

9.  ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

Authors:  Michael D Hogarty; Murray D Norris; Kimberly Davis; Xueyuan Liu; Nicholas F Evageliou; Candace S Hayes; Bruce Pawel; Rong Guo; Huaqing Zhao; Eric Sekyere; Joanna Keating; Wayne Thomas; Ngan Ching Cheng; Jayne Murray; Janice Smith; Rosemary Sutton; Nicola Venn; Wendy B London; Allen Buxton; Susan K Gilmour; Glenn M Marshall; Michelle Haber
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  [Topically applied arginine hydrochloride. Effect on urea content of stratum corneum and skin hydration in atopic eczema and skin aging].

Authors:  P Nenoff; K Donaubauer; T Arndt; U-F Haustein
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.